Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
EGFR INHIBITORS AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/046221
Kind Code:
A1
Abstract:
Disclosed herein are compounds or pharmaceutically acceptable salts thereof that are useful as EGFR inhibitors. Also disclosed are pharmaceutical compositions comprising such compounds, and methods of using such compounds or compositions to treat EGFR-related disorder (e.g., cancers).

Inventors:
ZENG QINGBEI (CN)
TSUI HONCHUNG (CN)
YANG ZHENFAN (CN)
ZHANG XIAOLIN (CN)
Application Number:
PCT/CN2023/114848
Publication Date:
March 07, 2024
Filing Date:
August 25, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
DIZAL JIANGSU PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D498/22; A61K31/4545; A61P35/00; A61P37/00
Domestic Patent References:
WO2022187363A12022-09-09
WO2023001069A12023-01-26
WO2022204544A12022-09-29
WO2022166741A12022-08-11
Foreign References:
CN115433207A2022-12-06
CN115368378A2022-11-22
CN114656482A2022-06-24
CN114057771A2022-02-18
CN114007698A2022-02-01
CN113527335A2021-10-22
CN114163454A2022-03-11
CN114907379A2022-08-16
CN104379575A2015-02-25
CN104520291A2015-04-15
Attorney, Agent or Firm:
JUN HE LAW OFFICES (CN)
Download PDF: